A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: marks (231), results (1000)

Annual-report-and-quality-account-2019-20

Description
ANNUAL REPORT AND ACCOUNTS 2019/20 Incorporating the quality account 2019/20 Page 2 University Hospital Southampton NHS Foundation Trust Annual
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/annual-report-and-quality-account-2019-202.pdf

Erlotinib

Description
Chemotherapy Protocol LUNG CANCER – NON-SMALL CELL (NSCLC) ERLOTINIB Regimen NSCLC - Erlotinib Indication Second line therapy of stage IIIB or IV
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lung-cancer-non-small-cellNSCLC/Erlotinibver12.pdf

Aria ePrescribing v13.6 MR1.2 user training guide

Description
Aria E-Prescribing v13.6 MR1.2 User Training Guide Every effort has been made to ensure that the material in
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/User-guides/Aria-ePrescribing-v13.6-MR1.2-user-training-guide.pdf

Darolutamide

Description
Chemotherapy Protocol PROSTATE CANCER DAROLUTAMIDE Regimen • Prostate - Darolutamide Indication • Darolutamide is recommended where the; - patient has a proven histological or cytological
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Prostatecancer/Darolutamide.pdf

Ibrutinib (WM) (420mg)

Description
Chemotherapy Protocol Waldenström's Macroglobulinaemia (WM) Regimen Ibrutinib • WM – Ibrutinib (420mg) Indication • The treatment of adult patients with Waldenström's Macroglobulinaemia (WM) who
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Ibrutinib-WM-420mg.pdf

Trabectedin v1

Description
Chemotherapy Protocol SARCOMA Regimen TRABECTEDIN Sarcoma-Trabectedin Indication Trabectedin is recommended as a possible treatment for people with advanced soft tissue
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/Trabectedin-v1.pdf

MifamurtideVer1.1

Description
Chemotherapy Protocol SARCOMA MIFAMURTIDE Regimen Sarcoma-Mifamurtide Indication Children, adolescents and young adults (30 years of age or less) with osteosarcoma
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Sarcoma/MifamurtideVer1.1.pdf

Cisplatin (100)-Radiotherapy

Description
Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (100) RT Regimen Head and Neck Cancer – Cisplatin (100) RT Indication Radical treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin100-Radiotherapy.pdf

Cisplatin (100) RT (21 day)

Description
Chemotherapy Protocol HEAD AND NECK CANCER CISPLATIN (100) RT (21 day) Regimen Head and Neck Cancer – Cisplatin (100) RT (21 day
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Headandneckcancer/Cisplatin-100-RT-21-day.pdf

GvHDProphylaxisMethotrexateTReplete

Description
Chemotherapy Protocol SUPPORT REGIMEN–GvHD PROPHYLAXIS METHOREXATE – T Replete Allograft Graft versus Host Disease (GvHD) Prophylaxis This regimen will only be
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Transplant/GvHDProphylaxisMethotrexateTReplete.pdf
481 to 490 of 548
Previous … 47 48 49 50 51 … Next